Related Experiment Videos
Colon cancer and apoptosis
Sergio Huerta1, Emily J Goulet, Edward H Livingston
1Department of Gastrointestinal and Endocrine Surgery, University of Texas Southwestern Medical Center/Veterans Administration North Texas Health Care System, Dallas, TX 75216, USA. sergio.huerta@utsouthwestern.edu
American Journal of Surgery
|March 15, 2006
Summary
This review explores apoptosis, or programmed cell death, in colon cancer. Understanding how cancer cells evade apoptosis is key to developing new treatments that enhance chemotherapy and immune response.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Metastatic colon cancer treatment requires understanding apoptosis.
- Colon cancer cells develop resistance to chemotherapy and evade the immune system.
Purpose of the Study:
- To review molecular apoptosis mechanisms in colon cancer.
- To examine the role of apoptosis in colon cancer progression and therapeutic resistance.
Main Methods:
- Comprehensive literature review on apoptosis.
- Analysis of molecular pathways involved in colon cancer cell death.
Main Results:
- Apoptosis is a critical factor in colon cancer development.
- Defects in apoptosis pathways contribute to therapeutic resistance and immune evasion.
Conclusions:
- Targeting apoptosis offers a promising strategy for colon cancer treatment.
- Modulating apoptosis can enhance chemoprevention, immuno-regulation, and metastasis control.
- Restoring immune recognition of cancer cells through apoptosis pathway manipulation is a potential therapeutic avenue.